Welcome to Shenzhen Sing Fung Intelligent  Manufacturing Co., Ltd.

E-mail:shaobo@sfi-crf.com

img
搜索
确认
取消
News Center

News Center

Professional plasma plasma high-tech enterprise dedicated to providing manufacturing equipment and process solutions for the electronics industry
News

Application of improving biocompatibility of plasma-injected plasma

  • Categories:Industry News
  • Author:plasma cleaning machine-surface treatment equipment-CRF plasma machine-Sing Fung Intelligent Manufacturing
  • Origin:
  • Time of issue:2020-10-26
  • Views:

(Summary description)Improving the biocompatibility of materials is another successful application of plasma ion implantation, which can be applied independently or in combination with PVD or CVD processes. For example, standard low temperature isotropic pyrolytic carbon shows strong image shape thrombotic aggregation in vivo, but titanium-based biomaterials treated with PIII oxygen do not appear obvious thrombotic after being put into vivo. Through oxygen ion bombardment, oxide growth is controlled and rutile phase is formed. In addition, the biocompatibility of PIII treated LTI carbon materials was also greatly improved, and the platelet density was significantly reduced after implantation in vivo. It may be caused by the formation of the CN surface layer after nitrogen injection. Until now, these materials, which are very useful, have not been used in conventional surgery, because there are many obstacles. For example, the law stipulates that "a long process of testing and clinical trials is required before a new synthetic material can be implanted into the human body." This requires a legal procedure.   PII has been successfully applied to ion implantation of nonmetallic materials. When conventional ion implantation is used, non-metallic materials are easy to be charged. Since the ions on the material surface will be repelled by static electricity, when PII treatment is carried out in the plasma environment, the electrons in the plasma will automatically complete charge neutralization.

Application of improving biocompatibility of plasma-injected plasma

(Summary description)Improving the biocompatibility of materials is another successful application of plasma ion implantation, which can be applied independently or in combination with PVD or CVD processes. For example, standard low temperature isotropic pyrolytic carbon shows strong image shape thrombotic aggregation in vivo, but titanium-based biomaterials treated with PIII oxygen do not appear obvious thrombotic after being put into vivo. Through oxygen ion bombardment, oxide growth is controlled and rutile phase is formed. In addition, the biocompatibility of PIII treated LTI carbon materials was also greatly improved, and the platelet density was significantly reduced after implantation in vivo. It may be caused by the formation of the CN surface layer after nitrogen injection. Until now, these materials, which are very useful, have not been used in conventional surgery, because there are many obstacles. For example, the law stipulates that "a long process of testing and clinical trials is required before a new synthetic material can be implanted into the human body." This requires a legal procedure.

 

PII has been successfully applied to ion implantation of nonmetallic materials. When conventional ion implantation is used, non-metallic materials are easy to be charged. Since the ions on the material surface will be repelled by static electricity, when PII treatment is carried out in the plasma environment, the electrons in the plasma will automatically complete charge neutralization.


  • Categories:Industry News
  • Author:plasma cleaning machine-surface treatment equipment-CRF plasma machine-Sing Fung Intelligent Manufacturing
  • Origin:
  • Time of issue:2020-10-26 09:22
  • Views:
Information

Application of improving biocompatibility of plasma-injected plasma:

 

Improving the biocompatibility of materials is another successful application of plasma ion implantation, which can be applied independently or in combination with PVD or CVD processes. For example, standard low temperature isotropic pyrolytic carbon shows strong image shape thrombotic aggregation in vivo, but titanium-based biomaterials treated with PIII oxygen do not appear obvious thrombotic after being put into vivo. Through oxygen ion bombardment, oxide growth is controlled and rutile phase is formed. In addition, the biocompatibility of PIII treated LTI carbon materials was also greatly improved, and the platelet density was significantly reduced after implantation in vivo. It may be caused by the formation of the CN surface layer after nitrogen injection. Until now, these materials, which are very useful, have not been used in conventional surgery, because there are many obstacles. For example, the law stipulates that "a long process of testing and clinical trials is required before a new synthetic material can be implanted into the human body." This requires a legal procedure.

 

PII has been successfully applied to ion implantation of nonmetallic materials. When conventional ion implantation is used, non-metallic materials are easy to be charged. Since the ions on the material surface will be repelled by static electricity, when PII treatment is carried out in the plasma environment, the electrons in the plasma will automatically complete charge neutralization.

Application of improving biocompatibility of plasma-injected plasma

Scan the QR code to read on your phone

Relevant Information

Shenzhen Sing Fung Intelligent  Manufacturing Co., Ltd.

Adhere to quality as the foundation, honesty as the way of business, innovation as the source of development, and service as the pinnacle of value

©Shenzhen Sing Fung Intelligent Manufacturing Co., Ltd. All rights reserved
粤ICP备19006998号
dh

TEL:0755-3367 3020 / 0755-3367 3019

dh

E-mail:sales-sfi@sfi-crf.com

dh

ADD:Mabao Industrial Zone, Huangpu, Baoan District, Shenzhen